Business Description
Qingdao Vland Biotech Co Ltd
ISIN : CNE100003GX8
Share Class Description:
SHSE:603739: Class ACompare
Compare
Traded in other countries / regions
603739.China IPO Date
2019-01-16Description
Qingdao Vland Biotech Co Ltd is a biotechnology company. The company is engaged in research and development of four main product categories which are enzymes, probiotics, vaccines and animal health products.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.75 | |||||
| Equity-to-Asset | 0.58 | |||||
| Debt-to-Equity | 0.43 | |||||
| Debt-to-EBITDA | 6.21 | |||||
| Interest Coverage | 12.87 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.41 | |||||
| Beneish M-Score | -2.47 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.3 | |||||
| 3-Year EBITDA Growth Rate | 1.7 | |||||
| 3-Year EPS without NRI Growth Rate | -13.8 | |||||
| 3-Year FCF Growth Rate | -54.8 | |||||
| 3-Year Book Growth Rate | 13.6 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.26 | |||||
| 9-Day RSI | 39.71 | |||||
| 14-Day RSI | 41.47 | |||||
| 6-1 Month Momentum % | -19.64 | |||||
| 12-1 Month Momentum % | -22.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.28 | |||||
| Quick Ratio | 1.07 | |||||
| Cash Ratio | 0.62 | |||||
| Days Inventory | 96.86 | |||||
| Days Sales Outstanding | 88.03 | |||||
| Days Payable | 76.49 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.04 | |||||
| Dividend Payout Ratio | 0.32 | |||||
| 3-Year Dividend Growth Rate | 3.8 | |||||
| Forward Dividend Yield % | 1.04 | |||||
| 5-Year Yield-on-Cost % | 1.03 | |||||
| 3-Year Average Share Buyback Ratio | -5.2 | |||||
| Shareholder Yield % | -9.9 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 44.69 | |||||
| Operating Margin % | 10.54 | |||||
| Net Margin % | 5.85 | |||||
| FCF Margin % | -4.65 | |||||
| ROE % | 4.28 | |||||
| ROA % | 2.63 | |||||
| ROIC % | 5.06 | |||||
| ROC (Joel Greenblatt) % | 7.69 | |||||
| ROCE % | 5.96 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 36.11 | |||||
| PE Ratio without NRI | 31.55 | |||||
| PS Ratio | 2.08 | |||||
| PB Ratio | 1.46 | |||||
| Price-to-Tangible-Book | 1.68 | |||||
| Price-to-Operating-Cash-Flow | 24.86 | |||||
| EV-to-EBIT | 22.3 | |||||
| EV-to-EBITDA | 22.3 | |||||
| EV-to-Revenue | 2.16 | |||||
| EV-to-FCF | -50.34 | |||||
| Price-to-Projected-FCF | 13.82 | |||||
| Price-to-Graham-Number | 1.54 | |||||
| Earnings Yield (Greenblatt) % | 4.48 | |||||
| FCF Yield % | -2.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Qingdao Vland Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,213.389 | ||
| EPS (TTM) (Â¥) | 0.27 | ||
| Beta | 0.96 | ||
| Volatility % | 35.71 | ||
| 14-Day RSI | 41.47 | ||
| 14-Day ATR (Â¥) | 0.589476 | ||
| 20-Day SMA (Â¥) | 10.809 | ||
| 12-1 Month Momentum % | -22.65 | ||
| 52-Week Range (Â¥) | 7.7 - 18.26 | ||
| Shares Outstanding (Mil) | 253.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Qingdao Vland Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Qingdao Vland Biotech Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Qingdao Vland Biotech Co Ltd Frequently Asked Questions
What is Qingdao Vland Biotech Co Ltd(SHSE:603739)'s stock price today?
The current price of SHSE:603739 is ¥9.75. The 52 week high of SHSE:603739 is ¥18.26 and 52 week low is ¥7.70.
When is next earnings date of Qingdao Vland Biotech Co Ltd(SHSE:603739)?
The next earnings date of Qingdao Vland Biotech Co Ltd(SHSE:603739) is .
Does Qingdao Vland Biotech Co Ltd(SHSE:603739) pay dividends? If so, how much?
The Dividend Yield %  of Qingdao Vland Biotech Co Ltd(SHSE:603739) is 1.04% (As of Today), Highest Dividend Payout Ratio of Qingdao Vland Biotech Co Ltd(SHSE:603739) was 1. The lowest was 0.32. And the median was 0.47. The  Forward Dividend Yield % of Qingdao Vland Biotech Co Ltd(SHSE:603739) is 1.04%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers